Stock Ticker

  • Loading stock data...

Gilead Sciences, Inc. (NASDAQ:GILD) Wins Street’s Hearts With Competitive Hepatitis C Drug Pricing

Boston, MA 10/13/2014 (wallstreetpr) – Gilead Sciences, Inc. (NASDAQ:GILD) is expected to reflect the positivity of the last week in its share prices today as well. The pharma company achieved a major milestone two days back when it recieved the U.S. Food and Drug Administration (FDA)’s nod for its hepatitis C drug. The regulatory approval […]

Sign Up To Get Our Latest Stocks Alerts